Beam Therapeutics
BEAM
Beam Therapeutics (BEAM) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $80.00 | Aug 25, 2026 |
| B of A Securities | Maintained | Buy | $47.00 | Jul 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $80.00 | Jul 7, 2026 |
| Bernstein | Maintained | Outperform | $39.00 from $40.00 | May 13, 2026 |
| Citigroup | Maintained | Buy | $68.00 from $64.00 | Mar 26, 2026 |
| Wedbush | Maintained | Outperform | $65.00 from $57.00 | Feb 25, 2026 |
| RBC Capital | Maintained | Sector Perform | $26.00 from $22.00 | Feb 25, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $74.00 | Feb 20, 2026 |
| Bernstein | Maintained | Outperform | $41.00 from $37.00 | Jan 21, 2026 |
| UBS | Initiated Coverage | Neutral | $28.00 | Jan 7, 2026 |
| Evercore ISI Group | Initiated Coverage | Outperform | $35.00 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $80.00 | Oct 10, 2025 |
| JP Morgan | Maintained | Overweight | $46.00 from $48.00 | Oct 9, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $80.00 | Sep 15, 2025 |
| Barclays | Maintained | Equal-Weight | $21.00 from $25.00 | Aug 6, 2025 |
| Barclays | Maintained | Equal-Weight | $25.00 from $31.00 | May 7, 2025 |
| Wells Fargo | Maintained | Overweight | $70.00 from $75.00 | May 7, 2025 |
| Guggenheim | Maintained | Buy | $55.00 from $78.00 | May 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $80.00 | Apr 7, 2025 |
| B of A Securities | Upgraded | Neutral → Buy | $42.00 | Mar 28, 2025 |
Frequently asked questions
What is the latest analyst rating on BEAM?
On Aug 25, 2026, HC Wainwright & Co. maintained Beam Therapeutics at Buy with a price target of $80.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.